Conduit Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $698,221 | $671,992 | $624,861 | $1,076,964 |
Gross Profit | -885 | -828 | -190 | -452 |
EBITDA | -6,282 | -5,143 | -4,380 | -994 |
EBIT | -7,167 | -5,971 | -4,577 | -1,446 |
Net Income | -7,118 | -6,028 | -4,753 | -2,406 |
Net Change In Cash | 698,221 | 671,992 | 624,861 | 1,076,964 |
Free Cash Flow | 65,325 | -2,581 | -24,761 | -3,813 |
Cash | 3,838 | 3,332 | 2,130 | 554 |
Basic Shares | 540 | 137 | 32 | 6 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $922,222 | $0 | $0 | $0 |
Gross Profit | -457 | |||
EBITDA | -15,839 | 3,053 | -4,887 | -3,173 |
EBIT | -16,296 | -324 | -3,160 | -488 |
Net Income | -17,802 | -535 | -4,887 | -3,657 |
Net Change In Cash | 922,222 | 0 | 0 | 0 |
Free Cash Flow | -9,733 | -7,725 | -2,266 | -2,151 |
Cash | 554 | 4,228 | 345 | 48 |
Basic Shares | 7 | 5 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$13.16 |
2025-06-30 | -$5.46 |
2025-03-31 | -$19.86 |
2024-12-31 | -$2.15 |
